AMGN

Amgen

Health Care

Biotechnology

Thousand Oaks, California

Balance Sheet 29 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$12.0B	$10.9B	$7.6B	$8.0B	$6.3B
Assets - MarketableSecuritiesCurrent	$11.5B	$0	$1.7B	$48.0M	$4.4B
Assets - AccountsReceivable	$6.8B	$7.3B	$5.6B	$4.9B	$4.5B
Assets - Inventories	$7.0B	$9.5B	$4.9B	$4.1B	$3.9B
Assets - PrepaidExpensesAndOtherCurrentAssets	$3.3B	$2.6B	$2.4B	$2.4B	$2.1B
Assets - TotalCurrentAssets	$29.0B	$30.3B	$22.2B	$19.4B	$21.1B
Assets - Property,PlantAndEquipment	$6.5B	$5.9B	$5.4B	$5.2B	$4.9B
Assets - Goodwill	$18.6B	$18.6B	$15.5B	$14.9B	$14.7B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$27.7B	$32.6B	$16.1B	$15.2B	$16.6B
Assets - DeferredTaxAssets	$5.0B	$4.6B	$2.8B	$1.7B	$1.3B
Assets - OperatingLeaseAssets	$557.0M	$651.0M	$579.0M	$566.0M	$408.0M
Assets - OtherNoncurrentAssets	$9.9B	$9.6B	$5.9B	$6.5B	$5.6B
Assets - TotalAssets	$91.8B	$97.2B	$65.1B	$61.2B	$62.9B
Liabilities - AccountsPayable	$1.9B	$1.6B	$1.6B	$1.4B	$1.4B
Liabilities - AccruedLiabilities	$17.6B	$15.4B	$12.5B	$10.7B	$10.1B
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$3.5B	$1.4B	$1.6B	$87.0M	$91.0M
Liabilities - OperatingLeaseLiabilitiesCurrent	$107.0M	$119.0M	$156.0M	$145.0M	$153.0M
Liabilities - TotalCurrentLiabilities	$23.1B	$18.4B	$15.7B	$12.2B	$11.7B
Liabilities - LongTermDebt	$56.5B	$63.2B	$37.4B	$33.2B	$32.9B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$673.0M	$691.0M	$539.0M	$525.0M	$306.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$3.0B	$3.4B	$1.6B	$1.2B	$201.0M
Liabilities - OtherNoncurrentLiabilities	$2.3B	$2.3B	$2.7B	$2.5B	$2.0B
Equity - PreferredStock	$5.0M	$5.0M	$5.0M	$5.0M	$5.0M
Equity - CommonStock	$3.3B	$3.3B	$3.3B	$3.3B	$3.3B
Equity - RetainedEarnings(deficit)	$-27.6B	$-26.5B	$-28.6B	$-24.6B	$-21.4B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-66.0M	$-289.0M	$-231.0M	$-796.0M	$-985.0M
Equity - TotalStockholdersEquity	$5.9B	$6.2B	$3.7B	$6.7B	$9.4B
Equity - TotalLiabilitiesAndStockholdersEquity	$91.8B	$97.2B	$65.1B	$61.2B	$62.9B

Income Statement 19 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/ProductSales	$33.4B	$28.2B	$26.3B	$26.0B	$25.4B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold/CostOfSales	$12.9B	$8.5B	$6.4B	$6.5B	$6.2B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$6.0B	$4.8B	$4.4B	$4.8B	$4.2B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$7.1B	$6.2B	$5.4B	$5.4B	$5.7B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$4.8B	$3.2B	$2.6B	$2.6B	$2.8B
IncomeStatement - OtherIncomeExpense - OperatingIncome(loss)	$7.3B	$7.9B	$9.6B	$7.6B	$9.1B
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/securities	$-21.0M	$98.0M	$-165.0M	$161.0M	$37.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$506.0M	$2.8B	$-814.0M	$259.0M	$256.0M
IncomeStatement - OtherIncomeExpense - Income(loss)BeforeIncomeTaxes	$4.6B	$7.9B	$7.3B	$6.7B	$8.1B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$519.0M	$1.1B	$794.0M	$808.0M	$869.0M
IncomeStatement - IncomeTax - EffectiveTaxRate	$0	$0	$0	$0	$0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$4.1B	$6.7B	$6.6B	$5.9B	$7.3B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$4.1B	$6.7B	$6.6B	$5.9B	$7.3B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$8	$13	$12	$10	$12
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$8	$12	$12	$10	$12
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$537.0M	$535.0M	$538.0M	$570.0M	$586.0M
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$541.0M	$538.0M	$541.0M	$573.0M	$590.0M
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$4.3B	$6.7B	$7.1B	$6.1B	$6.8B

Cash Flow Statement 23 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$4.1B	$6.7B	$6.6B	$5.9B	$7.3B
CashFlow - OperatingActivities - DepreciationAndAmortization	$5.6B	$4.1B	$3.4B	$3.4B	$3.6B
CashFlow - OperatingActivities - ShareBasedCompensation	$530.0M	$431.0M	$401.0M	$341.0M	$330.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-1.2B	$-1.2B	$-1.3B	$-434.0M	$-363.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$-3.1B	$-567.0M	$555.0M	$-140.0M	$1.3B
CashFlow - OperatingActivities - NetCashFromOperatingActivities	$11.5B	$8.5B	$9.7B	$9.3B	$10.5B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e)	$1.1B	$1.1B	$936.0M	$880.0M	$608.0M
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$0	$1.0M	$2.6B	$8.9B	$8.5B
CashFlow - InvestingActivities - ProceedsFromSales/maturitiesOfMarketableSecurities/investments	$0	$1.1B	$98.0M	$4.4B	$2.6B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$0	$27.0B	$3.8B	$2.5B	$0
CashFlow - InvestingActivities - OtherInvestingActivities	$-50.0M	$-225.0M	$-100.0M	$192.0M	$75.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities	$-1.0B	$-26.2B	$-6.0B	$733.0M	$-5.4B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$0	$27.8B	$6.9B	$4.9B	$8.9B
CashFlow - FinancingActivities - RepaymentsOfDebt	$3.6B	$1.5B	$0	$4.2B	$6.5B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$200.0M	$0	$6.4B	$5.0B	$3.5B
CashFlow - FinancingActivities - PaymentOfDividends	$4.9B	$4.6B	$4.3B	$4.1B	$3.8B
CashFlow - FinancingActivities - PaymentsRelatedToTaxWithholdingForShareBasedCompensation	$256.0M	$134.0M	$139.0M	$149.0M	$169.0M
CashFlow - FinancingActivities - OtherFinancingActivities	$-124.0M	$-72.0M	$-103.0M	$-78.0M	$-90.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities	$-9.4B	$21.0B	$-4.0B	$-8.3B	$-4.9B
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$1.0B	$3.3B	$-360.0M	$1.7B	$229.0M
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$2.9B	$3.4B	$2.4B	$1.9B	$1.4B
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$126.0M	$245.0M	$191.0M	$340.0M	$101.0M

Amgen

Balance Sheet 29 Accounts • 5 Years

Income Statement 19 Accounts • 5 Years

Cash Flow Statement 23 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History